NCT05180461 - Emodepside Phase II Trial for Treatment of Onchocerciasis | Biotech Hunter

Enrollment

578

Participants

Timeline

Start Date

August 30, 2021

Primary Completion Date

September 18, 2026

Study Completion Date

October 2, 2026

Conditions

Onchocerciasis

Interventions

DRUG

emodepside

emodepside tablet

DRUG

matching placebo of emodepside

emodepside matching placebo tablet

DRUG

ivermectin

ivermectin tablet (overencapsulated for blinding)

DRUG

matching placebo of ivermectin

matching placebo of overencapsulated ivermectin tablet

Trial Locations (3)

Centre de santé de référence de Kimpese, Kimpese

Hôpital général de référence de Masimanimba, Masi-Manimba

University of Health and Allied Services School of Public Health, Hohoe